Stock Market Blog
Daily stock market analysis, trade alerts, and trading education from Ross Givens and the Traders Agency team.
Starbucks to Close About 250 North American Cafes, Expects $300 Million Restructuring Charge
Starbucks will close about 250 underperforming North American cafes and expects roughly $300 million in restructuring charges, while cutting its fiscal 2026 store-growth outlook, CNBC and other outlets reported Thursday.
SoftBank Raises Record $11.1 Billion in High-Yield Bonds to Fund Final OpenAI Payment
SoftBank issued $11.1 billion in dollar- and euro-denominated senior notes to fund the final $10 billion tranche of its $30 billion OpenAI investment, in what LSEG data show is the largest high-yield corporate bond sale on record.
Meta Unveils $1,299.99 VR Glasses, New Ray-Ban Meta Audio Line and December-Bound Muse Charm Pendant
Meta detailed a $1,299.99 VR Glasses headset for spring 2027, a new Ray-Ban Meta Audio glasses line and a $249 Meta Adventurer, plus an unpriced Muse Charm pendant due in December, as JPMorgan lifted its Meta price target and Airbnb, Booking and Expedia sold off.
Barry Diller's People Inc. Withdraws $48.30-a-Share MGM Resorts Bid; BofA Cuts Stock to Neutral
Barry Diller's People Inc. withdrew its $48.30-a-share bid for MGM Resorts, citing deal complexity. MGM shares fell 9% and BofA moved the stock to neutral.
Oracle Shares Drop 4% After Bloomberg Report of 'Force Majeure' Notice on Project Jupiter Data Center
Oracle shares fell 4% after a Bloomberg report, cited by CNBC, said the company sent a force majeure notice on its Project Jupiter data center to developer Blue Owl Capital's unit. Bloom Energy shares fell 5.4% pre-market.
FDA Panel Backs GRAIL's Galleri Blood Test on Benefit-Risk, But Effectiveness Vote Exposes Data Gaps
An FDA advisory panel voted 7-2 that Galleri's benefits outweigh its risks but split 6-4 on effectiveness, with reviewers and GRAIL citing the same trial data differently ahead of a final FDA decision.
FDA Approves Eli Lilly's Once-Weekly Insulin Onswik for Type 2 Diabetes
Eli Lilly said the FDA approved Onswik (insulin efsitora alfa), a once-weekly basal insulin for adults with type 2 diabetes, about six months after Novo Nordisk's Awiqli won U.S. clearance.
Bessent Says U.S.-China Trade Truce Extended to Jan. 10 as Xi Arrives in Washington
Treasury Secretary Scott Bessent says the U.S. and China extended their trade truce two months to Jan. 10 as Xi Jinping began a state visit to Washington, with Beijing yet to publicly confirm the terms.
10-Year Treasury Yield Hits Highest Level Since 2007 as Hot PMI Data Boosts Fed Hike Odds
The 10-year Treasury yield jumped to 5.106%, its highest since 2007, after S&P Global flash PMI data beat forecasts and lifted market odds of an October Fed rate hike.
Paychex Q1 FY2027: Revenue Rises 6% to $1.63 Billion, but Management Solutions Miss Sends Shares Lower
Paychex's fiscal Q1 2027 revenue rose 6% to $1.63 billion, but 4% growth in its largest segment, Management Solutions, missed analyst estimates and pressured shares even as full-year guidance held steady.
Stock Market Today: Materials Leads While S&P 500 Slips
Materials led the session while the S&P 500 slips. See the validated market scorecard, sector performance, and what traders are watching next.
Rivian Recalls About 100,700 EVs Over Software Bug That Can Block Rearview Camera Display
Rivian is recalling about 100,700 EVs, with 98,828 covered by the U.S. filing, after NHTSA documents showed a software prompt could obstruct the rearview camera display; Rivian says most vehicles already have the over-the-air fix.
Stop watching.
Start winning.
50,000+ traders get our daily brief before the market opens.
You're subscribed!
Check your inbox.
Free. No spam. Unsubscribe anytime.
